Fresenius Medical Care AG & Co. KGaA (FMS)
Automate Your Wheel Strategy on FMS
With Tiblio's Option Bot, you can configure your own wheel strategy including FMS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol FMS
- Rev/Share 33.2607
- Book/Share 24.4141
- PB 0.9614
- Debt/Equity 0.8307
- CurrentRatio 1.4373
- ROIC 0.0395
- MktCap 12758371466.0754
- FreeCF/Share 3.9644
- PFCF 5.4842
- PE 19.4359
- Debt/Assets 0.3523
- DivYield 0.0312
- ROE 0.047
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework
Published: August 11, 2025 by: PRNewsWire
Sentiment: Neutral
Total volume of the initial share buyback is up to EUR 1 billion over two years Share buyback to take place until August 10, 2027 BAD HOMBURG, Germany , Aug. 11, 2025 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, announced the launch of the first tranche of its initial EUR 1 billion share buyback, which is part of its new capital allocation framework as presented at its Capital Markets Day on June 17. Today, the first tranche of up to EUR 600 million was initiated, which is planned …
Read More
FMS vs. OFIX: Which Stock Should Value Investors Buy Now?
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Instruments stocks are likely familiar with Fresenius (FMS) and Orthofix (OFIX). But which of these two stocks presents investors with the better value opportunity right now?
Read More
FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y
Published: August 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Fresenius Medical stock rises as Q2 earnings and revenues top estimates, driven by solid organic growth and expanding margins.
Read More
Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript
Published: August 05, 2025 by: Seeking Alpha
Sentiment: Neutral
Fresenius Medical Care AG (NYSE:FMS ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants s - Corporate Participant o - Corporate Participant P - Corporate Participant Dominik Heger - Executive VP and Head of Investor Relations, Strategic Development & Communications Helen Giza - Chair of Management Board & CEO Martin Fischer - CFO & Member of the Management Board Conference Call Participants David James Adlington - JPMorgan Chase & Co, Research Division Falko Friedrichs - Deutsche Bank AG, Research Division Graham Doyle - UBS Investment Bank, Research Division Hassan Al-Wakeel - Barclays Bank PLC, Research Division …
Read More
Here's Why Fresenius (FMS) Looks Ripe for Bottom Fishing
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
Fresenius (FMS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Read More
Here's Why Fresenius (FMS) is a Strong Value Stock
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Is the Options Market Predicting a Spike in Fresenius Medical Stock?
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors need to pay close attention to FMS stock based on the movements in the options market lately.
Read More
FMS or SONVY: Which Is the Better Value Stock Right Now?
Published: July 21, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Fresenius (FMS) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Negative
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
Read More
4 High Earnings Yield Value Stocks You Should be Owning
Published: July 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Unlock your portfolio value by investing in stocks like FMS, EGO, HOPE and HRTG.
Read More
FMS vs. RXST: Which Stock Is the Better Value Option?
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or RxSight, Inc. (RXST). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
FMS Stock Likely to Gain on New Optimization Plan FME Reignite
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Fresenius Medical Care unveils FME Reignite, targeting one billion euros in cost savings, tech upgrades and enhanced shareholder returns.
Read More
FMS or RXST: Which Is the Better Value Stock Right Now?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or RxSight, Inc. (RXST). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency
Published: June 17, 2025 by: Benzinga
Sentiment: Positive
Fresenius Medical Care AG FMS on Tuesday introduced a strategic roadmap — FME Reignite — aimed at revitalizing its core business, driving innovation and reshaping its organizational culture.
Read More
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Negative
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
Read More
Fresenius (FMS) Upgraded to Buy: Here's Why
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Fresenius (FMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History
Published: May 22, 2025 by: PRNewsWire
Sentiment: Neutral
Shareholders approved the proposed dividend of 1.44 Euro per share, representing a 21 percent increase year-over-year and marking the highest dividend in the company's history Excellent progress in the company's transformation and turnaround plans continues to strengthen the foundation for sustainable, profitable growth In 2024, organic revenue growth1 was 4 percent, and operating income increased by 18 percent on an outlook base2, coming in at the upper end of the company's outlook The company is well positioned for double digit earnings growth in 2025, translating to an 11-12 percent margin BAD HOMBURG, Germany , May 22, 2025 /PRNewswire/ -- Fresenius …
Read More
Here's Why Fresenius (FMS) is a Strong Value Stock
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Fresenius (FMS) is a Great Momentum Stock: Should You Buy?
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Fresenius (FMS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Five high-flying medical instrument stocks are: DXCM, IDXX, NPCE, CLPT, FMS.
Read More
New Strong Buy Stocks for May 9th
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
CBNA, FMS, BNTGY, WYY and BCRX have been added to the Zacks Rank #1 (Strong Buy) List on May 9, 2025.
Read More
Best Value Stocks to Buy for May 9th
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
BNTGY, SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 9, 2025.
Read More
Best Income Stocks to Buy for May 9th
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 9, 2025.
Read More
FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth.
Read More
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Fresenius Medical Care starts 2025 with strong organic revenue and income growth
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
Strong organic revenue growth1 of 5% driven by Care Enablement and Care Delivery Stable U.S. same market treatment development despite impact from a severe flu season FME25 savings of EUR 68 million contributed to earnings Operating income2 grew 11% at constant currency resulting in margin expansion Reported operating income grew by 35% and reported net income3 by 113% Net leverage ratio further improved to 2.8x and FY 2025 outlook confirmed BAD HOMBURG, Germany , May 6, 2025 /PRNewswire/ -- "The results of the first quarter of 2025 once again demonstrate our continuous operational and financial progress as we are executing …
Read More
Fresenius Medical Care tops market expectations in 1st quarter
Published: May 06, 2025 by: Reuters
Sentiment: Positive
World's largest dialysis specialist Fresenius Medical Care reported first-quarter results above analysts' expectations on Tuesday, as revenue grew organically in all its segments, it said.
Read More
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Positive
MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.
Read More
About Fresenius Medical Care AG & Co. KGaA (FMS)
- IPO Date 1996-09-17
- Website https://www.freseniusmedicalcare.com
- Industry Medical - Care Facilities
- CEO Helen Giza
- Employees 112035